Allergic Rhinitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2010-07-23
Clinical Trial Update: The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) [Phase 3]
Phase 3 trial evaluating montelukast for perennial allergic rhinitis; study completed with results posted in 2010.
FDA approval · 2010-07-12
FDA Approved: DESLORATADINE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Desloratadine from Dr. Reddy's Laboratories Limited as an original ANDA, making a generic desloratadine available for use in al…
CLINICAL_TRIALS trial_result · 2010-07-05
Clinical Trial Update: Home Usability of a Nasal Lavage System in Children
The clinical trial evaluating at-home usability of a nasal lavage system in children has completed. Results were posted in July 2010.
FDA approval · 2010-06-29
FDA Approved: KIRKLAND SIGNATURE ALLERCLEAR D 24 HR EXTENDED RELEASE — Supplemental Application (Kirkland-COSTCO WHOLESALE COMPANY)
FDA granted supplemental approval for Kirkland Signature Allerclear D 24 HR Extended Release, a loratadine and pseudoephedrine sulfate combi…
FDA approval · 2010-06-21
FDA Approved: AZELASTINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved the original ANDA for azelastine hydrochloride nasal spray from Sun Pharmaceutical Industries, enabling a generic version. …
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2010-06-17
Clinical Trial Update: Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen [Phase 2]
Phase 2 trial investigating immunogenicity of Grass MATA at different doses in subjects with grass and rye pollen allergy; study is complete…
CLINICAL_TRIALS trial_result · 2010-06-17
Clinical Trial Update: Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen [Phase 2]
Phase 2 trial evaluating different doses of TreeMATA for induction of immunogenicity in people with tree pollen allergy. The study status is…
CLINICAL_TRIALS trial_result · 2010-06-17
Clinical Trial Update: Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine [Phase 2]
A Phase 2 clinical trial evaluated the contribution of Monophosphoryl Lipid A (MPL) as an adjuvant to a tree pollen allergy vaccine; the stu…
CLINICAL_TRIALS trial_result · 2010-06-17
Clinical Trial Update: Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing [Phase 1]
Phase 1 study assessing the residual allergenicity of a ragweed pollen allergoid formulated with Monophosphoryl Lipid A (MPL) using skin pri…
CLINICAL_TRIALS trial_result · 2010-06-17
Clinical Trial Update: Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen [Phase 1]
This Phase 1 trial assesses the safety, immunological effects, and potential efficacy of combining MPL adjuvant with a grass pollen allergen…
FDA approval · 2010-06-15
FDA Approved: ALLERGY RELIEF — Original Application (WALGREENS)
FDA approved Walgreens' ALLERGY RELIEF as an original ANDA for cetirizine hydrochloride, establishing a generic antihistamine option. The pr…
CLINICAL_TRIALS trial_result · 2010-06-07
Clinical Trial Update: Sublingual Immunotherapy In Alternaria-Induced Rhinitis [Phase 4]
Phase 4 clinical trial of sublingual immunotherapy for Alternaria-induced allergic rhinitis (with asthma) has completed.
CLINICAL_TRIALS trial_result · 2010-06-04
Clinical Trial Update: Probiotics for Reduction Of Markers In Subjects With Allergy [NA]
This completed clinical trial evaluated whether probiotics can reduce allergy-related biomarkers in participants with hay fever due to birch…
CLINICAL_TRIALS trial_result · 2010-06-02
Clinical Trial Update: A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response. [Phase 1]
Phase 1 trial assessing the effect of a single dose of ibuprofen or fluticasone propionate on inflammatory markers and allergen response aft…
CLINICAL_TRIALS trial_result · 2010-05-31
Clinical Trial Update: Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
Pilot clinical trial update evaluating allergy immunotherapy for prevention of viral respiratory infections in individuals with allergic rhi…
FDA approval · 2010-05-28
FDA Approved: FEXOFENADINE HCL AND PSEUDOEPHEDRINE HCI — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application from Dr. Reddy's Laboratories Limited for a fexofenadine HCl and pseudoephedrine HCl combination pro…
FDA approval · 2010-05-27
FDA Approved: BETR REMEDIES ALL DAY ALLERGY RELIEF — Supplemental Application (Live Betr LLC)
The FDA approved a supplemental application for BETR REMEDIES ALL DAY ALLERGY RELIEF, a cetirizine hydrochloride product from Live Betr LLC.
CLINICAL_TRIALS trial_result · 2010-05-05
Clinical Trial Update: Long-term Efficacy and Safety Study With Oralgen Grass Pollen [Phase 2, Phase 3]
The document announces the completion of a long-term efficacy and safety study (Phase 2/Phase 3) evaluating Oralgen Grass Pollen for allergi…
CLINICAL_TRIALS trial_result · 2010-05-05
Clinical Trial Update: A Study of the Effects of Single Dose Corticosteroids on Response to Allergens [Phase 1]
A Phase 1 clinical trial evaluating the effects of a single dose of corticosteroids on response to allergens in individuals with allergic rh…
CLINICAL_TRIALS trial_result · 2010-04-30
Clinical Trial Update: An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma [Phase 3]
Phase 3 exploratory trial results for mometasone furoate (Nasonex) in adults with moderate-to-severe persistent allergic rhinitis and interm…
FDA label_change · 2010-04-26
FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair to update labeling; Organon LLC submitted the request.
FDA approval · 2010-04-14
FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochloride) …
FDA approval · 2010-04-14
FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Allegra-D Allergy and Congestion (fexofenadine hydrochloride and pseudoephedrine hydrochlori…
FDA label_change · 2010-04-06
FDA Approved: CETIRIZINE HCL — Supplemental Application (AMERISOURCE BERGEN)
FDA approved a supplemental application for cetirizine HCl submitted by Amerisource Bergen, indicating a labeling change to the product.
FDA label_change · 2010-03-10
FDA Approved: COUNTERACT ALLERGY — Supplemental Application (Melaleuca, Inc.)
The FDA approved Melaleuca, Inc.'s supplemental application for COUNTERACT ALLERGY (loratadine), resulting in a labeling update for the prod…